{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:51:39Z","timestamp":1791827499462,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Drug Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Generative structure-prediction models can directly predict protein-ligand complexes from sequence and ligand information, but their ability to capture pharmacologically relevant kinase-inhibitor interactions remains incompletely understood. We systematically evaluated Boltz-2 using curated biochemical IC\n                    <jats:sub>50<\/jats:sub>\n                    measurements across eight human kinases, nine clinically used inhibitors, and representative resistance mutations. Although predicted log\n                    <jats:sub>10<\/jats:sub>\n                    (IC\n                    <jats:sub>50<\/jats:sub>\n                    ) values showed a compressed dynamic range relative to experimental measurements, mutation-dependent shifts in inhibitor sensitivity, inhibitor selectivity patterns, and overall potency rankings showed substantial agreement with the experimental patterns within the present benchmark. Predicted binding probability showed good discrimination between binder and non-binder pairs within the present benchmark and a consistent inverse relationship with experimental potency. Structural analyses showed that ligand-pose variability was associated with prediction behavior within the evaluated kinase-inhibitor systems, even when kinase-domain structures showed close agreement with the corresponding experimental structures. Larger ligand RMSD values were not associated with larger prediction errors in magnitude, but were linked to systematic shifts in prediction bias, indicating that ligand-pose accuracy and predictive utility are not equivalent measures of Boltz-2 performance. These findings suggest that, within the present benchmark, relative kinase-inhibitor interaction patterns were reproduced more consistently than absolute potency values. We provide a framework for interpreting Boltz-2 outputs within the kinase-inhibitor systems examined here.\n                  <\/jats:p>","DOI":"10.1038\/s44386-026-00086-x","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:29:52Z","timestamp":1791826192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Benchmarking Boltz-2 for relative kinase-inhibitor interaction patterns across conformational states and resistance mutations"],"prefix":"10.1038","volume":"3","author":[{"given":"Atsushi","family":"Suenaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Okimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"86_CR1","first-page":"701","volume":"5","author":"D Fabbro","year":"2002","unstructured":"Fabbro, D. & Garc\u00eda-Echeverr\u00eda, C. Targeting protein kinases in cancer therapy. Curr. Opin. Drug Discov. Devel. 5, 701\u2013712 (2002).","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"86_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrd773","volume":"1","author":"P Cohen","year":"2002","unstructured":"Cohen, P. Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1, 309\u2013315 (2002).","journal-title":"Nat. Rev. Drug Discov."},{"key":"86_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrc2559","volume":"9","author":"J Zhang","year":"2009","unstructured":"Zhang, J., Yang, P. L. & Gray, N. S. Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer 9, 28\u201339 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"86_CR4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon, M. A. & Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 141, 1117\u20131134 (2010).","journal-title":"Cell"},{"key":"86_CR5","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","volume":"112","author":"BJ Druker","year":"2008","unstructured":"Druker, B. J. Translation of the Philadelphia chromosome into therapy for CML. Blood 112, 4808\u20134817 (2008).","journal-title":"Blood"},{"key":"86_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrc2656","volume":"9","author":"J Baselga","year":"2009","unstructured":"Baselga, J. & Swain, S. M. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat. Rev. Cancer 9, 463\u2013475 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"86_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.18632\/oncotarget.262","volume":"2","author":"RB Corcoran","year":"2011","unstructured":"Corcoran, R. B., Settleman, J. & Engelman, J. A. Potential therapeutic strategies to overcome acquired resistance to BRAF or MEK inhibitors in BRAF mutant cancers. Oncotarget 2, 336\u2013346 (2011).","journal-title":"Oncotarget"},{"key":"86_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota, S. et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577\u2013580 (1998).","journal-title":"Science"},{"key":"86_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1126\/science.1079666","volume":"299","author":"MC Heinrich","year":"2003","unstructured":"Heinrich, M. C. et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299, 708\u2013710 (2003).","journal-title":"Science"},{"key":"86_CR10","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.bbamcr.2012.03.017","volume":"1823","author":"JT Tigno-Aranjuez","year":"2012","unstructured":"Tigno-Aranjuez, J. T. & Abbott, D. W. Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease. Biochim. Biophys. Acta 1823, 2022\u20132028 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"86_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0092-8674(02)00741-9","volume":"109","author":"M Huse","year":"2002","unstructured":"Huse, M. & Kuriyan, J. The conformational plasticity of protein kinases. Cell 109, 275\u2013282 (2002).","journal-title":"Cell"},{"key":"86_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nchembio799","volume":"2","author":"Y Liu","year":"2006","unstructured":"Liu, Y. & Gray, N. S. Rational design of inhibitors that bind to inactive kinase conformations. Nat. Chem. Biol. 2, 358\u2013364 (2006).","journal-title":"Nat. Chem. Biol."},{"key":"86_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tibs.2010.09.006","volume":"36","author":"SS Taylor","year":"2011","unstructured":"Taylor, S. S. & Kornev, A. P. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem. Sci. 36, 65\u201377 (2011).","journal-title":"Trends Biochem. Sci."},{"key":"86_CR14","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre, M. E. et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293, 876\u2013880 (2001).","journal-title":"Science"},{"key":"86_CR15","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0709662105","volume":"105","author":"CH Yun","year":"2008","unstructured":"Yun, C. H. et al. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc. Natl. Acad. Sci. USA 105, 2070\u20132075 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"86_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nm.3854","volume":"21","author":"KS Thress","year":"2015","unstructured":"Thress, K. S. et al. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M. Nat. Med. 21, 560\u2013562 (2015).","journal-title":"Nat. Med."},{"key":"86_CR17","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1021\/jm050362n","volume":"49","author":"GL Warren","year":"2006","unstructured":"Warren, G. L. et al. A critical assessment of docking programs and scoring functions. J. Med. Chem. 49, 5912\u20135931 (2006).","journal-title":"J. Med. Chem."},{"key":"86_CR18","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/molecules23081899","volume":"23","author":"T Pantsar","year":"2018","unstructured":"Pantsar, T. & Poso, A. Binding affinity via docking: fact and fiction. Molecules 23, 1899 (2018).","journal-title":"Molecules"},{"key":"86_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev-biophys-070816-033654","volume":"46","author":"DL Mobley","year":"2017","unstructured":"Mobley, D. L. & Gilson, M. K. Predicting binding free energies: frontiers and benchmarks. Annu. Rev. Biophys. 46, 531\u2013558 (2017).","journal-title":"Annu. Rev. Biophys."},{"key":"86_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"86_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"86_CR22","doi-asserted-by":"publisher","unstructured":"Evans, R. et al. Protein complex prediction with AlphaFold-Multimer. Preprint at https:\/\/doi.org\/10.1101\/2021.10.04.463034 (2021).","DOI":"10.1101\/2021.10.04.463034"},{"key":"86_CR23","doi-asserted-by":"publisher","unstructured":"Chai Discovery. Chai-1: Decoding the molecular interactions of life. Preprint at https:\/\/doi.org\/10.1101\/2024.10.10.615955 (2024).","DOI":"10.1101\/2024.10.10.615955"},{"key":"86_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl2528","volume":"384","author":"R Krishna","year":"2024","unstructured":"Krishna, R. et al. Generalized biomolecular modeling and design with RoseTTAFold All-Atom. Science 384, eadl2528 (2024).","journal-title":"Science"},{"key":"86_CR25","doi-asserted-by":"publisher","unstructured":"Passaro, S. et al. Boltz-2: Towards accurate and efficient binding affinity prediction. Preprint at https:\/\/doi.org\/10.1101\/2025.06.14.659707 (2025).","DOI":"10.1101\/2025.06.14.659707"},{"key":"86_CR26","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1021\/acs.jcim.5c02630","volume":"66","author":"G Bret","year":"2026","unstructured":"Bret, G., Sindt, F. & Rognan, D. Assessing Boltz-2 performance for the binding classification of docking hits. J. Chem. Inf. Model. 66, 1511\u20131521 (2026).","journal-title":"J. Chem. Inf. Model."},{"key":"86_CR27","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning, G. et al. The protein kinase complement of the human genome. Science 298, 1912\u20131934 (2002).","journal-title":"Science"},{"key":"86_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.1862342","volume":"253","author":"DR Knighton","year":"1991","unstructured":"Knighton, D. R. et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 407\u2013414 (1991).","journal-title":"Science"},{"key":"86_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd.2018.21","volume":"17","author":"FM Ferguson","year":"2018","unstructured":"Ferguson, F. M. & Gray, N. S. Kinase inhibitors: the road ahead. Nat. Rev. Drug Discov. 17, 353\u2013377 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"86_CR30","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nbt.1990","volume":"29","author":"MI Davis","year":"2011","unstructured":"Davis, M. I. et al. Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotechnol. 29, 1046\u20131051 (2011).","journal-title":"Nat. Biotechnol."},{"key":"86_CR31","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.bpj.2018.02.038","volume":"114","author":"RE Amaro","year":"2018","unstructured":"Amaro, R. E. et al. Ensemble docking in drug discovery. Biophys. J. 114, 2271\u20132278 (2018).","journal-title":"Biophys. J."},{"key":"86_CR32","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1021\/jm501603h","volume":"58","author":"RSK Vijayan","year":"2015","unstructured":"Vijayan, R. S. K. et al. Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors. J. Med. Chem. 58, 466\u2013479 (2015).","journal-title":"J. Med. Chem."},{"key":"86_CR33","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1128\/MCB.00248-15","volume":"35","author":"E Kovacs","year":"2015","unstructured":"Kovacs, E. et al. Analysis of the role of the C-terminal tail in the regulation of the epidermal growth factor receptor. Mol. Cell. Biol. 35, 3083\u20133102 (2015).","journal-title":"Mol. Cell. Biol."},{"key":"86_CR34","doi-asserted-by":"publisher","first-page":"a020768","DOI":"10.1101\/cshperspect.a020768","volume":"6","author":"MA Lemmon","year":"2014","unstructured":"Lemmon, M. A., Schlessinger, J. & Ferguson, K. M. The EGFR family: not so prototypical receptor tyrosine kinases. Cold Spring Harb. Perspect. Biol. 6, a020768 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"86_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13307","volume":"7","author":"SR Needham","year":"2016","unstructured":"Needham, S. R. et al. EGFR oligomerization organizes kinase-active dimers into competent signalling platforms. Nat. Commun. 7, 13307 (2016).","journal-title":"Nat. Commun."},{"key":"86_CR36","doi-asserted-by":"publisher","first-page":"7946","DOI":"10.1021\/acs.jmedchem.2c00487","volume":"65","author":"M Volkov","year":"2022","unstructured":"Volkov, M. et al. On the frustration to predict binding affinities from protein-ligand structures with deep neural networks. J. Med. Chem. 65, 7946\u20137958 (2022).","journal-title":"J. Med. Chem."},{"key":"86_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae081","volume":"25","author":"H Wang","year":"2024","unstructured":"Wang, H. Prediction of protein-ligand binding affinity via deep learning models. Brief. Bioinform. 25, bbae081 (2024).","journal-title":"Brief. Bioinform."},{"key":"86_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s42256-025-01160-1","volume":"8","author":"A Morehead","year":"2025","unstructured":"Morehead, A., Giri, N., Liu, J., Neupane, P. & Cheng, J. Assessing the potential of deep learning for protein-ligand docking. Nat. Mach. Intell. 8, 32\u201341 (2025).","journal-title":"Nat. Mach. Intell."},{"key":"86_CR39","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0092-8674(03)00194-6","volume":"112","author":"B Nagar","year":"2003","unstructured":"Nagar, B. et al. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112, 859\u2013871 (2003).","journal-title":"Cell"},{"key":"86_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1126\/science.aay0543","volume":"366","author":"Y Kondo","year":"2019","unstructured":"Kondo, Y. et al. Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases. Science 366, 109\u2013115 (2019).","journal-title":"Science"},{"key":"86_CR41","doi-asserted-by":"publisher","first-page":"D1633","DOI":"10.1093\/nar\/gkae1075","volume":"53","author":"T Liu","year":"2025","unstructured":"Liu, T. et al. BindingDB in 2024: a FAIR knowledgebase of protein\u2013small molecule binding data. Nucleic Acids Res. 53, D1633\u2013D1644 (2025).","journal-title":"Nucleic Acids Res."},{"key":"86_CR42","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 47, D1102\u2013D1109 (2019).","journal-title":"Nucleic Acids Res."},{"key":"86_CR43","unstructured":"UniProt Consortium. UniProt: the universal protein knowledgebase in 2025. Nucleic Acids Res. 53, D609\u2013D617 (2025)."},{"key":"86_CR44","doi-asserted-by":"publisher","first-page":"10691","DOI":"10.1021\/acs.jmedchem.2c00991","volume":"65","author":"C Shen","year":"2022","unstructured":"Shen, C. et al. Boosting protein-ligand binding pose prediction and virtual screening based on residue\u2013atom distance likelihood potential and graph transformer. J. Med. Chem. 65, 10691\u201310706 (2022).","journal-title":"J. Med. Chem."},{"key":"86_CR45","unstructured":"RDKit: Open-source cheminformatics. http:\/\/www.rdkit.org (2026)."},{"key":"86_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open Babel: An open chemical toolbox. J. Cheminform. 3, 33 (2011).","journal-title":"J. Cheminform."},{"key":"86_CR47","unstructured":"Case, D. A. et al. Amber 24 (University of California, 2024)."},{"key":"86_CR48","doi-asserted-by":"publisher","first-page":"114502","DOI":"10.1063\/5.0019056","volume":"153","author":"X He","year":"2020","unstructured":"He, X., Man, V. H., Yang, W., Lee, T.-S. & Wang, J. A fast and high-quality charge model for the next generation general AMBER force field. J. Chem. Phys. 153, 114502 (2020).","journal-title":"J. Chem. Phys."},{"key":"86_CR49","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian, C. et al. ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J. Chem. Theory Comput. 16, 528\u2013552 (2020).","journal-title":"J. Chem. Theory Comput."},{"key":"86_CR50","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"86_CR51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"J-P Ryckaert","year":"1977","unstructured":"Ryckaert, J.-P., Ciccotti, G. & Berendsen, H. J. C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327\u2013341 (1977).","journal-title":"J. Comput. Phys."},{"key":"86_CR52","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: An N\u00b7log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."},{"key":"86_CR53","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/prot.20033","volume":"55","author":"A Onufriev","year":"2004","unstructured":"Onufriev, A., Bashford, D. & Case, D. A. Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins 55, 383\u2013394 (2004).","journal-title":"Proteins"},{"key":"86_CR54","unstructured":"Schr\u00f6dinger, LLC. The PyMOL Molecular Graphics System, Version 3.0. Schr\u00f6dinger, LLC, New York, NY (2024)."}],"container-title":["npj Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00086-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:29:54Z","timestamp":1791826194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00086-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1038\/s44386-026-00086-x","relation":{},"ISSN":["3005-1452"],"issn-type":[{"value":"3005-1452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"15 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"46"}}